Riskpilot← Back to searchSign inGet full accessCIMPAX A/S
A/SActiveCVR 31363799Lille Pilevang 4Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20089 employees
Revenue 2025
DKK 12,5M
+55% vs 2024
EBITDA margin
53.2%
+185% vs 2024
Equity ratio
24.8%
Financial strength
Net profit 2025
DKK 3,1M
+382% vs 2024
| Revenue | DKK 12,5M | +55% |
| EBITDA | DKK 6,7M | +185% |
| Net profit | DKK 3,1M | +382% |
| Total assets | DKK 27M | +42% |
| Equity | DKK 6,7M | +86% |
| Employees | 9 | — |
Legal name
CIMPAX A/S
CVR number
31363799
Legal form
Aktieselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
1. april 2008
Share capital
DKK 400.000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene eller af bestyrelsesformanden alene eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at udvikle, fremstille og sælge medicinsk udstyr
Address
Lille Pilevang 4
Phone
+4555380381
Email
cvr@cimpax.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -916 | -1.749 | 2.905 | 4.619 | 4.152 | 3.647 | 3.398 | 5.474 | 6.388 | 5.300 | 5.300 | 7.995 | 8.079 | 12.535 |
| Staff expenses | -894 | -1.064 | -2.170 | -3.037 | -3.969 | -3.417 | -2.967 | -4.148 | -4.323 | -4.383 | -4.159 | -5.541 | -5.742 | -5.865 |
| EBITDA | 77 | -533 | 735 | 1.582 | 183 | 229 | 431 | 1.327 | 2.064 | 917 | 1.141 | 2.455 | 2.337 | 6.670 |
| Depreciation & amort. | -49 | -76 | -111 | -167 | -177 | -151 | -209 | -456 | -519 | -372 | -427 | -501 | -902 | -905 |
| EBIT | 28 | -609 | 624 | 1.415 | 7 | 78 | 222 | 871 | 1.545 | 545 | 714 | 1.953 | 1.435 | 5.765 |
| Net financials | -92 | -152 | -140 | -129 | -213 | -211 | -272 | -231 | -280 | -303 | -346 | -827 | -608 | -1.822 |
| Profit before tax | 119 | -461 | 484 | 1.286 | -206 | -133 | -50 | 639 | 1.265 | 242 | 368 | 1.127 | 827 | 3.943 |
| Tax | -0 | 31 | 131 | 316 | -40 | -164 | 136 | 149 | 263 | 90 | 86 | 228 | 188 | 864 |
| Net profit | 119 | -492 | 353 | 970 | -167 | 30 | -187 | 491 | 1.002 | 153 | 282 | 899 | 639 | 3.080 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.588 | 2.673 | 3.983 | 5.612 | 6.341 | 6.779 | 6.996 | 7.839 | 8.987 | 8.972 | 13.507 | 15.572 | 19.038 | 26.956 |
| Equity | 535 | 43 | 310 | 1.095 | 528 | 559 | 372 | 863 | 1.865 | 1.782 | 2.063 | 2.962 | 3.601 | 6.681 |
| Long-term debt | -300 | 0 | 1.973 | 1.129 | 2.585 | 3.820 | 3.820 | 3.642 | 3.131 | 844 | 6.906 | 6.823 | 6.431 | 6.688 |
| Short-term debt | -1.823 | -2.716 | 1.669 | 3.358 | 3.228 | 2.400 | 2.642 | 3.116 | 3.824 | 6.193 | 4.268 | 5.250 | 8.572 | 13.193 |
| Total debt | -2.123 | -2.716 | 3.642 | 4.488 | 5.813 | 6.220 | 6.462 | 6.758 | 6.955 | 7.037 | 11.174 | 12.073 | 15.003 | 19.881 |
EBITDA margin
53.2%
This company
15.8%
Market median
+237% vs market
20122025
Equity ratio
24.8%
This company
38.2%
Market median
-35% vs market
20122025
Return on equity
46.1%
This company
18.4%
Market median
+151% vs market
20122025
Net profit margin
24.6%
This company
8.1%
Market median
+204% vs market
20122025
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20122025
Debt / equity
3.03×
This company
0.62×
Market median
-389% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PB Management | Management | 2008 | — | — |
PA Management | Management | 2008 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Cimpax Holding A/S | Company | 100.0% | 100.0% | 2021 |
PBM PAX HOLDING ApS | Company | 50.0% | 50.0% | 2008 |
MBM CIM HOLDING ApS | Company | 50.0% | 50.0% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
J.J. HAGELSKJÆR HOLDING ApS
CIMPAX A/S Board members of CIMPAX A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Patrick Busch-Madsen | Management | 0 companies |
| Peter Andreas Stakemann | Management | 0 companies |
| Michael Busch-Madsen | Chairman | 0 companies |
| Jens Jørgen Hagelskjær | Board of Directors | 0 companies |